Redcare Pharmacy's Independent Deputy Chairman Boosts Stake with 29% More Stock

Redcare Pharmacy NV, a leading online pharmacy in Europe, has seen its Independent Deputy Chairman of the Supervisory Board, [Name], acquire an additional 29% of the company's shares. This significant investment comes on top of the chairman's previous holdings, indicating a strong vote of confidence in the company's future prospects. The acquisition aligns with Redcare Pharmacy's recent financial performance and growth prospects, as well as its strategic initiatives.

Redcare Pharmacy's recent financial performance has been robust, with the company reporting a record year in 2023. The company achieved a 49% increase in revenue, reaching EUR 1.8 billion, and a 3.7 percentage point improvement in its adjusted EBITDA margin, which stood at 3% for the full year. The company also met all elements of its 2023 guidance, demonstrating its strong operational execution and financial discipline.

The acquisition of MediService AG, a leading online pharmacy in Switzerland, has further strengthened Redcare Pharmacy's position in the market. The partnership combines online pharmacy expertise with specialty-Rx leadership in Switzerland, enabling Redcare Pharmacy to expand its reach and customer base. This strategic move is expected to drive further growth and improve the company's earnings potential.



Redcare Pharmacy's growth prospects remain strong, with the company expecting to continue both fast sales growth (30-40%) and solidly positive margins (adjusted EBITDA 2-4%) in 2024. The company's strong financial performance, combined with its strategic initiatives, has attracted the attention of the Independent Deputy Chairman, who has chosen to invest further in the company's future.

The acquisition of an additional 29% of the company's shares by the Independent Deputy Chairman of the Supervisory Board sends a clear signal to the market and other investors about the company's potential. It demonstrates the chairman's confidence in Redcare Pharmacy's ability to continue delivering strong financial performance and executing its strategic initiatives.

In conclusion, Redcare Pharmacy's Independent Deputy Chairman of the Supervisory Board's acquisition of an additional 29% of the company's shares is a strong endorsement of the company's future prospects. The acquisition aligns with the company's recent financial performance and growth prospects, as well as its strategic initiatives. As the company continues to execute its strategy and deliver strong financial results, investors can expect Redcare Pharmacy to remain a compelling investment opportunity in the online pharmacy sector.